SPAG9 May Be a Potential Prognostic Marker of Endometrial Hyperplasia and Grade 1 Endometrioid Adenocarcinoma Treated with Progestin.

Li, Chunyan

SPAG9 May Be a Potential Prognostic Marker of Endometrial Hyperplasia and Grade 1 Endometrioid Adenocarcinoma Treated with Progestin. [electronic resource] - Gynecologic and obstetric investigation 2016 - 267-74 p. digital

Publication Type: Journal Article

1423-002X

10.1159/000437015 doi


Adaptor Proteins, Signal Transducing--analysis
Adult
Antineoplastic Agents, Hormonal--therapeutic use
Biomarkers, Tumor--analysis
Blotting, Western
Carcinoma, Endometrioid--diagnosis
Cell Line, Tumor
Early Detection of Cancer--methods
Endometrial Hyperplasia--diagnosis
Endometrial Neoplasms--diagnosis
Female
Humans
Immunohistochemistry
Medroxyprogesterone Acetate--therapeutic use
Prognosis
Real-Time Polymerase Chain Reaction
Reverse Transcriptase Polymerase Chain Reaction